HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anthrax toxins induce shock in rats by depressed cardiac ventricular function.

Abstract
Anthrax infections are frequently associated with severe and often irreversible hypotensive shock. The isolated toxic proteins of Bacillus anthracis produce a non-cytokine-mediated hypotension in rats by unknown mechanisms. These observations suggest the anthrax toxins have direct cardiovascular effects. Here, we characterize these effects. As a first step, we administered systemically anthrax lethal toxin (LeTx) and edema toxin (EdTx) to cohorts of three to twelve rats at different doses and determined the time of onset, degree of hypotension and mortality. We measured serum concentrations of the protective antigen (PA) toxin component at various time points after infusion. Peak serum levels of PA were in the microg/mL range with half-lives of 10-20 minutes. With doses that produced hypotension with delayed lethality, we then gave bolus intravenous infusions of toxins to groups of four to six instrumented rats and continuously monitored blood pressure by telemetry. Finally, the same doses used in the telemetry experiments were given to additional groups of four rats, and echocardiography was performed pretreatment and one, two, three and twenty-four hours post-treatment. LeTx and EdTx each produced hypotension. We observed a doubling of the velocity of propagation and 20% increases in left ventricular diastolic and systolic areas in LeTx-treated rats, but not in EdTx-treated rats. EdTx-but not LeTx-treated rats showed a significant increase in heart rate. These results indicate that LeTx reduced left ventricular systolic function and EdTx reduced preload. Uptake of toxins occurs readily into tissues with biological effects occurring within minutes to hours of serum toxin concentrations in the microg/mL range. LeTx and EdTx yield an irreversible shock with subsequent death. These findings should provide a basis for the rational design of drug interventions to reduce the dismal prognosis of systemic anthrax infections.
AuthorsLinley E Watson, Shu-Ru Kuo, Khurshed Katki, Tongyun Dang, Seong Kyu Park, David E Dostal, Wei-Jen Tang, Stephen H Leppla, Arthur E Frankel
JournalPloS one (PLoS One) Vol. 2 Issue 5 Pg. e466 (May 23 2007) ISSN: 1932-6203 [Electronic] United States
PMID17520025 (Publication Type: Journal Article)
Chemical References
  • Antigens, Bacterial
  • Bacterial Toxins
  • Viper Venoms
  • anthrax toxin
  • edema factor
Topics
  • Animals
  • Antigens, Bacterial (blood, toxicity)
  • Bacterial Toxins (blood, toxicity)
  • Heart (drug effects, physiopathology)
  • Heart Ventricles (drug effects, physiopathology)
  • Rats
  • Rats, Sprague-Dawley
  • Shock (chemically induced)
  • Viper Venoms (blood, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: